Skip to main content

Series B Therapeutics Companies

Explore 190 therapeutics startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
190
Total Funding
$1.6B
Avg Funding
$64.2M
Cities
20

Export 190 Series B Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States

Monument is an online treatment platform that offers alcohol addiction treatment, telehealth, teletherapy, and therapy services.

Dec 2023
Series B

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$41.5M
raised

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

Nov 2023
Series B

Founder Contacts

41,000+ verified contacts

Risskov, Denmark
$81.4M
raised

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Nov 2023
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$35.2M
raised

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

Oct 2023
Series B

Founder Contacts

41,000+ verified contacts

Chicago, United States
$81.0M
raised

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Sep 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$109.0M
raised

Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$13.0M
raised

Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Berkeley, United States
$60.0M
raised

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Cleveland, United States
$17.6M
raised

Enspire DBS Therapy supports stroke recovery patients using deep brain stimulation with physical rehabilitation to restore motor function.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$30.0M
raised

Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.

Jul 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Natick, United States
$50.0M
raised

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

Mar 2023
Series B

Founder Contacts

41,000+ verified contacts

Watertown, United States
$125.0M
raised

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$107.0M
raised

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$78.0M
raised

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Jan 2023
Series B

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$25.0M
raised

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

Jan 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Emeryville, United States
$100.0M
raised

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Jan 2023
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$175.0M
raised

Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.

Jan 2023
Series B

Founder Contacts

41,000+ verified contacts

Burlington, United States
$115.0M
raised

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Jan 2022
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$95.0M
raised

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Jan 2024
Series B

Founder Contacts

41,000+ verified contacts

Chicago, United States
$34.0M
raised

NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better.

Jan 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$20.0M
raised

Parallel is a provider of learning assessments and treatment solutions for students with learning and thinking differences.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Phoenix, United States
$50.0M
raised

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Woburn, United States
$110.0M
raised

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

New Haven, United States
$40.0M
raised

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

Jan 2022
Series B

Founder Contacts

41,000+ verified contacts

La Tronche, France
$13.3M
raised

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 190 companies

Ready to Connect with Series B Therapeutics Startups?

Get verified founder emails, funding details, and company data for 190 series b therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked